Dexcom (DXCM) Shares Outstanding (Diluted) (2013 - 2026)
Dexcom (DXCM) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 192.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 390.10 Mn |
| Mar 31, 2026 | 393.60 Mn |
| Dec 31, 2025 | 405.50 Mn |
| Sep 30, 2025 | 407.40 Mn |
| Jun 30, 2025 | 408.20 Mn |
| Mar 31, 2025 | 407.50 Mn |
| Dec 31, 2024 | 412.70 Mn |
| Sep 30, 2024 | 410.20 Mn |
| Jun 30, 2024 | 416.80 Mn |
| Mar 31, 2024 | 416.70 Mn |
| Dec 31, 2023 | 425.50 Mn |
| Sep 30, 2023 | 426.80 Mn |
| Jun 30, 2023 | 431.50 Mn |
| Mar 31, 2023 | 418.50 Mn |
| Dec 31, 2022 | 427.50 Mn |
| Sep 30, 2022 | 425.80 Mn |
| Jun 30, 2022 | 421.40 Mn |
| Mar 31, 2022 | 428.80 Mn |
| Dec 31, 2021 | 400.40 Mn |
| Sep 30, 2021 | 402.00 Mn |